These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26253934)

  • 21. Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis.
    Watson GS; Craft S
    J Neurol Sci; 2006 Jun; 245(1-2):21-33. PubMed ID: 16631207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of borderline diabetes on the risk of dementia and Alzheimer's disease.
    Xu W; Qiu C; Winblad B; Fratiglioni L
    Diabetes; 2007 Jan; 56(1):211-6. PubMed ID: 17192484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer's disease patients.
    Domínguez RO; Marschoff ER; González SE; Repetto MG; Serra JA
    Diabetes Res Clin Pract; 2012 Oct; 98(1):68-74. PubMed ID: 22658669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease.
    Alagiakrishnan K; Sankaralingam S; Ghosh M; Mereu L; Senior P
    Discov Med; 2013 Dec; 16(90):277-86. PubMed ID: 24333407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cerebral complications of diabetes mellitus].
    Aszalós Z
    Orv Hetil; 2007 Dec; 148(50):2371-6. PubMed ID: 18055361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global View on Alzheimer's Disease and Diabetes Mellitus: Threats, Risks and Treatment Alzheimer's Disease and Diabetes Mellitus.
    Klimova B; Kuca K; Maresova P
    Curr Alzheimer Res; 2018; 15(14):1277-1282. PubMed ID: 30251605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focus on the Correlations between Alzheimer's Disease and Type 2 Diabetes.
    Fiore V; De Rosa A; Falasca P; Marci M; Guastamacchia E; Licchelli B; Giagulli VA; De Pergola G; Poggi A; Triggiani V
    Endocr Metab Immune Disord Drug Targets; 2019; 19(5):571-579. PubMed ID: 30854980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common pathological processes and transcriptional pathways in Alzheimer's disease and type 2 diabetes.
    Jones A; Kulozik P; Ostertag A; Herzig S
    J Alzheimers Dis; 2009; 16(4):787-808. PubMed ID: 19387113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer's disease. The Real.FR cohort.
    Sanz CM; Hanaire H; Vellas BJ; Sinclair AJ; Andrieu S;
    Diabet Med; 2012 Apr; 29(4):541-8. PubMed ID: 21913970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exogenous galanin attenuates spatial memory impairment and decreases hippocampal β-amyloid levels in rat model of Alzheimer's disease.
    Li L; Yu L; Kong Q
    Int J Neurosci; 2013 Nov; 123(11):759-65. PubMed ID: 23687905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review.
    Mittal K; Katare DP
    Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S144-9. PubMed ID: 26907971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galanin peptide family as a modulating target for contribution to metabolic syndrome.
    Fang P; Yu M; Shi M; Zhang Z; Sui Y; Guo L; Bo P
    Gen Comp Endocrinol; 2012 Oct; 179(1):115-20. PubMed ID: 22909974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes mellitus in patients with Alzheimer's disease: clinical description and correlation with the APOE genotype in a sample population from the province of Antioquia, Colombia.
    Botero LE; Toro AE; Patiño AJ; Salazar G; Rodríguez JC; Suárez-Escudero JC; Alarcón GA; Corcimaru A; Osorio C; Jeong JS; Alzate O
    Biomedica; 2012 Jun; 32(2):239-51. PubMed ID: 23242298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease.
    Watson GS; Craft S
    Eur J Pharmacol; 2004 Apr; 490(1-3):97-113. PubMed ID: 15094077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neuropeptide galanin benefits insulin sensitivity in subjects with type 2 diabetes.
    Fang P; Yu M; Shi M; He B; Zhang Z; Bo P
    Curr Protein Pept Sci; 2013 Dec; 14(8):669-73. PubMed ID: 24106965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease.
    Crawley JN
    Exp Suppl; 2010; 102():133-41. PubMed ID: 21299066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's disease.
    Crawley JN
    Cell Mol Life Sci; 2008 Jun; 65(12):1836-41. PubMed ID: 18500642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Link between diabetes and Alzheimer's disease reinforced. Beta amyloid seen as the culprit-in-common; could lead to better understanding of AD and possible intervention.
    Health News; 2006 Oct; 12(10):3-4. PubMed ID: 17162791
    [No Abstract]   [Full Text] [Related]  

  • 39. Inflammation and NF-kappaB in Alzheimer's disease and diabetes.
    Granic I; Dolga AM; Nijholt IM; van Dijk G; Eisel UL
    J Alzheimers Dis; 2009; 16(4):809-21. PubMed ID: 19387114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dementia and diabetes: casual or causal relationship?].
    Formiga F; Reñe R; Pérez-Maraver M
    Med Clin (Barc); 2015 Feb; 144(4):176-80. PubMed ID: 24629693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.